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Abstract
Background: Women, who have been subjected to female genital mutilation (FGM), can suffer serious and
irreversible physical, psychological and psychosexual complications. They have more adverse obstetric outcomes as
compared to women without FGM. Exploratory studies suggest radical change to abandonment of FGM by
communities after migration to countries where FGM is not prevalent. Women who had been subjected to FGM as
a child in their countries of origin, require specialised healthcare to reduce complications and further suffering. Our
study compared obstetric outcomes in women with FGM to women without FGM who gave birth in a
metropolitan Australian hospital with expertise in holistic FGM management.
Methods: The obstetric outcomes of one hundred and ninety-six women with FGM who gave birth between 2006
and 2012 at a metropolitan Australian hospital were analysed. Comparison was made with 8852 women without
FGM who gave birth during the same time period. Data were extracted from a database specifically designed for
women with FGM and managed by midwives specialised in care of these women, and a routine obstetric database,
ObstetriX. The accuracy of data collection on FGM was determined by comparing these two databases. All women
with FGM type 3 were deinfibulated antenatally or during labour. The outcome measures were (1) maternal:
accuracy and grade of FGM classification, caesarean section, instrumental birth, episiotomy, genital tract trauma,
postpartum blood loss of more than 500 ml; and (2) neonatal: low birth weight, admission to a special care nursery,
stillbirth.
Results: The prevalence of FGM in women who gave birth at the metropolitan hospital was 2 to 3 %. Women with
FGM had similar obstetric outcomes to women without FGM, except for statistically significant higher risk of first
and second degree perineal tears, and caesarean section. However, none of the caesarean sections were performed
for FGM indications. The ObstetriX database was only 35 % accurate in recording the correct FGM type.
Conclusion: Women with FGM had similar obstetric outcomes to women without FGM in an Australian
metropolitan hospital with expertise in FGM management. Specialised FGM services with clinical practice guideline
and education of healthcare professionals may increase the detection rate of FGM and improve obstetric
management of women with FGM.
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Background
In 2013, the Australian Government’s national strategy
recognised the importance of ensuring quality health
services for girls and women with FGM and supporting
international collaboration to protect girls from this
harmful practice and help communities abandon it. Hos-
pitals in Australia are reporting increased presentations
of affected women in labour [1]. In Australia, little is
known of the prevalence of FGM, or the burden of dis-
ease attributed to the practice. This contrasts with avail-
able information in other countries such as the United
Kingdom (UK), France and Germany where there has
been migration from countries where FGM is prevalent.
For example, in 2007, 66,000 women were estimated to
be living with FGM in the UK [2].
FGM involves partial or total removal of the external
female genitalia or other injury to the female genital or-
gans for nonmedical reasons (Table 1) [3].
More than 200 million girls and women have under-
gone FGM, with three million at risk each year [4]. Girls
may die at the time of the cutting from haemorrhage or
septic shock [5], or experience considerable physical,
psychological and sexual complications [3, 6–8]. A pro-
spective study by the World Health Organization
(WHO) in six African countries has shown that obstetric
complications are significantly higher in women with
FGM [9]. Women with the more severe form of FGM,
i.e., type III or infibulation, had a 30 % higher risk of
caesarean section and a 70 % increase in postpartum
haemorrhage compared with those without FGM. The
perinatal mortality rate was 15, 32 and 55 % higher in
women with FGM type I, II and III, respectively [9].
In 2011, about 36,000 women and girls migrated to or
were asylum seekers in Australia from countries where
FGM is prevalent [10]. The number of refugee intake in
Australia, however, is small compared to most of the
other high income countries in the world. Moreover,
eighty-seven percent of refugees globally are hosted in
developing countries [11]. Even though the prevalence of
FGM is on the decline globally, and even if this progress
in reducing the total number of girls in the countries of
prevalence is maintained, the number of girls subjected
to FGM will still grow due to population growth [12].
With ongoing wars and conflicts, Australia and other
countries will continue to receive migrants, refugees and
asylum seekers, some of whom are from countries where
FGM is prevalent. A review on current knowledge on
cultural change after migration in FGM practice suggests
a significant shift towards abandonment [13]. There have
been fewer than 50 criminal court cases on FGM in
Western countries to date. Whilst it is possible that girls
are being cut secretly and without detection, there is far
greater evidence that migration is a positive catalyst for
attitude change [13].
Currently there are only three hospitals in Australia
that have expertise and policies in regards to the care of
women with FGM [14–16]. A coordinated national and
international approach to inform evidence-based care to
provide girls and women affected by this practice better
and more cost effective healthcare is required. Accurate
data on the prevalence and morbidity of FGM and train-
ing of healthcare professionals are prerequisites for this
endeavour. Our study examines the impact of FGM on
obstetric outcomes for women with FGM who were
cared for in a metropolitan Australian hospital with ex-
pertise in FGM management. We also assessed the ac-
curacy of data collection on FGM in this hospital.
Methods
The metropolitan hospital, where our study was based,
is a multicultural centre of excellence for the provision
of maternity and newborn care services for women with
low risk births. There are approximately 1500 births per
year at the hospital. The hospital’s patients speak 17 lan-
guages, with 67 % of the patients having a non-English
speaking background.
The hospital’s specialised FGM clinic follows guide-
lines by the Royal Australian and New Zealand College
of Obstetricians and Gynaecologists (RANZCOG) for
optimal maternity care of women with FGM [17]. The
presence and type of FGM is documented at the first
(booking) visit and a clear care pathway for antenatal
care, labour and birth is established and documented for
each woman. Counselling, psychological and translation
services are provided for women and their families.
FGM and its health risks, as well as the legal framework
around FGM are discussed. An opportunity is created
for women and their partners to explore their percep-
tions and beliefs regarding FGM. The benefits of deinfi-
bulation are explained and the procedure is offered
preferably in the second trimester to allow for vaginal
examinations to assess the progress in labour. It is, how-
ever, also performed during labour.
Deinfibulation is performed under local anaesthetic.
The woman’s vagina is incised open and the cut edges
sewn over in a subcuticular fashion for haemostasis and
healing. As part of their FGM prevention program, this
hospital conducts training on FGM for obstetricians and
Table 1 WHO Classification of FGM
Type I Partial or total removal of clitoris and/or prepuce
Type II Partial of total removal of clitoris and labia minora, with or
without excision of labia majora
Type III Infibulation. Excision of part or all of external genitalia and
stitching of the two cut sides together to varying degrees
Type IV All other harmful procedures to female genitalia for non-
medical purposes, for example pricking, piercing, incision,
stretching, scraping and cauterisation
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midwives, general practitioners and nurses specialising
in reproductive health. This involves teaching on the
sociocultural underpinnings of FGM, cultural compe-
tence, identification of the types of FGM, antenatal,
intrapartum, and postnatal care with surgical skills of
deinfibulation procedure, recognition of other physical
and psychosexual complications and appropriate refer-
rals for treatment, and the legal framework around FGM
to protect newborn girls. It also provides education ses-
sions for migrant women and their partners on FGM
throughout Australia. Antenatal care and definfibulation
procedures are provided by the specialist team of mid-
wives and obstetricians.
Our study population were all adult women with
singleton pregnancies who gave birth to their babies over
24 weeks at this hospital between 2006 and 2012. All
data was accessed retrospectively. The study was ap-
proved by the Scientific Advisory Committee and the
Human Research Ethics Committee of the Western
Local Health District. The data was de-identified for per-
sons prior to analysis. Two sets of data were available
containing information about women with FGM during
this time. The first dataset is ObstetriX [18], which is
completed by midwives at their first visit and after the
baby is born. ObstetriX was introduced in NSW in 2005
to replace various public hospital databases to track and
manage detailed maternal and neonatal information.
This database provides a space to record the presence
and type of FGM. The second database has been main-
tained since 2000 by the Clinical Midwifery Consultant
and midwives of the maternity ward who specialise in
the management of FGM (the Midwives Database). It is
hence considered to have accurate information on FGM
status due to the expertise of these midwives. In addition
to ObstetriX, the Midwives Database records the deinfi-
bulation procedures the midwives perform for women
with FGM type III prior to pregnancy, during their sec-
ond trimester or in labour.
From each database, we extracted information on
whether FGM was recorded, and the type of FGM, for
woman who had given birth. From the ObstetriX Database,
we extracted the following perinatal outcomes: caesarean
section, instrumental birth, medio-lateral episiotomy, geni-
tal tract trauma (first and second, third and fourth degree
perineal tears), postpartum blood loss of more than 500 ml,
admission of the newborn to the special care nursery, and
stillbirth. Stillbirth is defined as the complete expulsion or
extraction from its mother of a product of conception of at
least 20 weeks gestation or 400 g birth weight who did not,
at any time after birth, breathe, or show any evidence of life,
such as a heartbeat.
In the analysis of prevalence and the perinatal out-
comes, if there was a disagreement between the two da-
tabases in the recording of FGM, the Midwives Database
was deemed to be the correct record due to the FGM
expertise of the Clinical Midwife Consultant and mid-
wives. If the type of FGM for a woman differed at differ-
ent visits, then the most severe type was chosen as the
correct type and applied to all obstetric records for that
woman.
Statistical analysis
We cross-tabulated the FGM type recorded in the
ObstetriX Database with the FGM type recorded in the
Midwives Database for all women’s records between July
2006 and December 2012. We calculated the propor-
tions where FGM was recorded in both datasets and
where the FGM type agreed. We calculated the propor-
tion of women with FGM among women who gave birth
in the years 2006 to 2012. Among women with and
without FGM, we summarised categorical variables using
proportions. We fitted Poisson regression models, with
general estimating equations to account for subsequent
births for women over the years, to estimate the rate of
obstetric complications among women with FGM com-
pared with women without FGM. Additionally, for nul-
liparous women, we fitted a Poisson regression model to
assess the association between FGM type and caesarean
section rates after adjusting for the potential con-
founders year of birth, age group, body mass index
group, presence of hypertension and diabetes, and smok-
ing status. This analysis was performed only among nul-
liparous women to remove any effect of previous
obstetric history. We were unable to fit adjusted models
for the other obstetric outcomes due to their small num-
bers among nulliparous women.
Results
Comparison of FGM recording in ObstetriX and Midwives
Databases
There were 9048 maternity records for the period July
2006 to December 2012 for women with singleton preg-
nancies. ObstetriX recorded FGM in 139 records, whilst
the Midwives Database indicated that 180 records were
for women with FGM (Table 2). In this period, Obste-
triX documented FGM in 73 % (139/191) of all records
where FGM was recorded (ObstetriX or Midwives Data-
bases). This proportion increased from 14 % in 2006 to
90 % in 2012.
Among the records for women with FGM documented
in either database, the ObstretriX record agreed with the
Midwives database in only 35 % of cases and the Kappa
statistic was 0.28 (95 % CI: 0.18, 0.38). Approximately
39 % of FGM type III recordings in the Midwives Data-
base were recorded incorrectly as grade I-II or “unknown”
in ObstetriX. Among women with FGM recorded in
ObstetriX, the proportion of “unknown” classification was
high at 42 % (Table 2).
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Prevalence and type of FGM, and demographics of
women with FGM
There were 196 births from women with FGM at the
study hospital between 2006 and 2012 (Table 3). The
prevalence of women with FGM varied in year from 1.8
to 2.8 %. The highest prevalence occurred in 2009. The
percentages of women with FGM types I, II and III
among the known types were 33, 33, and 26 %,
respectively.
The majority (67 %) of women with FGM were
born in East Africa. Almost a quarter (23 %) were
from the western and southern regions of Africa, and
the remainder from North Africa, the Middle East
and Asia. The majority (89 %) of women with FGM
type III were from East Africa. Approximately half of
the women with FGM from Sudan and Somalia had
FGM type III. The prevalence of FGM was the same
among women from East Africa and those from west-
ern and southern regions of Africa, i.e., 45 %. The
prevalence among women from the other countries
was less than 1 %.
The age distribution for women with and without FGM
was similar, with most women aged between 20 and
34 years (Table 4). A third of the births among women with
FGM were to women who had three or more previous de-
liveries of babies, compared to 17 % among women without
FGM. Women with and without FGM were similar in body
mass index and the diagnosis of hypertension. Gestational
diabetes mellitus was more common among women with
FGM type III. Only 1 % of women with FGM were smokers
during pregnancy as compared to 5.6 % of women without
FGM.
Maternal and neonatal outcomes for women with and
without FGM
Table 5 displays the rates of maternal and neonatal out-
comes for women with different types of FGM and for
women without FGM. Almost all women with FGM type
III had deinfibulation performed either prior to or dur-
ing pregnancy. Only 9 % were deinfibulated during
labour.
Maternal and neonatal outcomes for women with
FGM were similar to those without FGM, except for sta-
tistically significant higher rates of caesarean section and
first and second degree perineal tears. The latter was
more common among women with FGM type III as
compared to types I and II (Table 5).
Table 3 Number of women who have FGM recorded and have a maternity record at the study hospital between 2006 and 2012, by
year
Number of women
FGM recorded FGM typea 2006b 2007 2008 2009 2010 2011 2012
Yes All types 15 25 33 37 29 35 22
Type III 6 10 10 13 5 13 7
Type II-III 0 0 1 0 0 0 0
Type II 2 7 7 12 11 11 7
Type I-II 0 1 1 3 1 2 0
Type I 4 5 12 7 11 8 6
Unknown 3 2 2 2 1 1 2
Percent of women with FGM recorded 2.3 1.8 2.4 2.8 2.2 2.4 1.5
No 631 1390 1344 1307 1306 1447 1427
aFGM status and type was determined from examining both the Midwives and ObstetriX Databases. If there was a disagreement between the two databases, the
Midwives Database was deemed to be the correct record. If the type of FGM for an individual woman differed at different visits, then the most severe type was
chosen as the correct type and applied to all obstetric records
FGM status was grouped as:
Type I/II = Unknown, Type I, Type I-II, Type II
Type III = Type II/III, Type III
b2006 includes only July to December
Table 2 Comparison of all obstetric records for women with













Type I-II 43 2 35 30 110









5 1 5 8857 8868
Total 58 23 58 8909 9048
aThe ObstetriX Database codes FGM as either Not known, Grade 1–2 or Grade
3–4, whereas the Midwives Database codes to the more specific type I, II or III
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Table 4 Demographics of women with FGM recorded at time of obstetric visit at study hospital between 2006 and 2012
FGM statusa FGM statusa
Type III Type I/II No Type III Type I/II No
n n n % % %
Age group
15–19 0 1 326 0.0 0.8 3.7
20–24 8 33 2243 12.3 25.2 25.3
25–29 21 29 2862 32.3 22.1 32.3
30–34 21 43 2216 32.3 32.8 25.0
35–39 11 22 972 16.9 16.8 11.0
40+ 4 3 233
Region of birth
East Africab 58 73 157 89.2 55.7 1.8
Western/Southern Africa 6 39 56 9.2 29.8 0.6
North Africa and Middle East 0 7 2057 0.0 5.3 23.2
Asia 1 12 2267 1.5 9.2 25.6
Others 0 0 4315 0.0 0.0 48.7
Parity
0 13 39 3444 0.0 29.8 38.9
1 9 35 2472 20.0 26.7 27.9
2 15 20 1408 13.8 15.3 15.9
3 14 18 808 23.1 13.7 9.1
4 or more 14 19 720 21.5 14.5 8.1
Number of previous preterm or nonviable pregnancies
0 44 61 5749 67.7 46.6 64.9
1 8 40 2051 12.3 30.5 23.2
2 9 10 710 13.8 7.6 8.0
3 3 14 206 4.6 10.7 2.3
4 or more 1 6 136 1.5 4.6 1.5
BMI
< 18.5 2 3 370 3.7 2.7 4.8
18.5–24.9 19 44 3982 35.2 40.0 51.2
25.0–29.9 21 43 2037 38.9 39.1 26.2
30+ 12 20 1387 22.2 18.2 17.8
Missing data 11 21 1076
Hypertension
Essential/Renal 0 0 30 0 0.0 0.3
Gestational/Pre-eclampsia/Eclampsia 3 5 318 4.7 3.8 3.6
No 61 125 8437 95.3 96.2 96.0
Missing data 1 1 67
Diabetes
Pre-existing 0 1 46 0 0.8 0.5
Gestational 11 10 655 17.2 7.7 7.5
No 53 119 8078 82.8 91.5 92.0
Missing data 1 1 73
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Caesarean section rates amongst nulliparous women with
FGM
Nulliparous women with FGM types III and I/II, and those
without FGM had a caesarean section rate of 46 % (n = 6),
40 % (n = 15), and 20 % (n = 697), respectively (Table 6).
Among nulliparous women, the crude relative risk of
having a caesarean section for women with FGM type III
compared to women without FGM was 2.3 (95 % CI:
1.3–4.1), and the adjusted relative risk was 1.5 (0.9–2.6).
Among nulliparae, the crude relative risk of having a
caesarean section for women with FGM Type I/II com-
pared to women without FGM was 1.8 (95 % CI: 1.2–
2.9), and the adjusted relative risk was 1.6 (CI 1.0–2.6).
Nulliparous women with FGM had higher rates of cae-
sarean section than women without FGM (P = 0.037).
Despite the statistically significant higher rates of cae-
sarean section among women with FGM, none of the
caesarean sections had FGM as an indication.
Indications for caesarean sections for women with FGM
Sixty-three percent of all caesarean sections for women
with FGM (multiparae and nulliparae) were emergency and
the remainder elective. Amongst emergency operations,
78 % had FGM type I/II. The indications were non-
reassuring fetal heart rate trace with or without abnormal
fetal scalp lactate (65 %), failure to progress (19 %), pre-
eclampsia (9 %), placental abruption (3 %) and placenta
praevia (3 %). Sixty-three percent underwent a caesarean
section at cervical dilatation of up to 4 cm.
The indications for all elective caesarean sections were
previous caesarean section (74 %, n = 14), malpresenta-
tion (21 %, n = 4), and meconium-stained liquor with no
labour (5 %, n = 1).
Amongst nulliparae, 81 % were emergency caesarean
sections. Most of them (71 %) were for non-reassuring
fetal heart rate trace. Two-thirds of these were induc-
tions of labour for postdates, 75 % of whom underwent
caesarean section at cervical dilatation of 2-4 cm. See
(Additional file 1: Table S7) for the original data used to
perform the above analysis.
Discussion
Main findings
The prevalence of women with FGM who gave birth at
the metropolitan hospital in Australia between 2006 and
2012, was 2 to 3 %. The accuracy of ObstetriX database
in collecting data on the presence of FGM increased
from 14 to 90 % over six years. However, it was only
35 % correct in identifying the type of FGM. Ninety per-
cent of women with FGM were born in the countries of
Africa. Two thirds of all women with FGM had types II
and III. Ninety percent of women with type III were
from East Africa. Half of the women from Somalia and
Sudan had FGM type III.
All women with FGM III were deinfibulated for the
birth of their baby unless an elective caesarean section
was performed. Caesarean section and genital tract
trauma were more common in women with FGM. The
latter was higher amongst women with FGM type III as
compared to types I and II. None of the women’s caesar-
ean sections were directly indicated for FGM.
Strengths and limitations
The main strength of the study is that it is the first avail-
able data on the number of women with FGM giving
birth at a hospital in Australia. It is also the first infor-
mation on obstetric and neonatal outcomes in women
with FGM in this country. Moreover, our study is one of
few in the literature to stratify obstetric complications
for FGM type. Our study highlights the importance of
the need for hospitals and healthcare professionals with
expertise in caring for women with FGM.
The small number of women with FGM in the obstet-
ric outcomes categories limited statistical analysis. Com-
bining datasets from multiple hospitals across Australia
and internationally may address this issue.
Table 4 Demographics of women with FGM recorded at time of obstetric visit at study hospital between 2006 and 2012
(Continued)
Smoking status in pregnancy
No 64 128 8321 100.0 98.5 94.4
Yes 0 2 495 0.0 1.5 5.6
Missing data 1 1 36 100.0 98.5 94.4
aFGM status and type were determined from examining both the ObstetriX and Midwives Databases. If there was a disagreement between the two databases, the
Midwives Database was deemed to be the correct record. If the type of FGM for an individual woman differed at different visits, then the most severe type was
chosen as the correct type and applied to all obstetric records
Women may have more than one obstetric record during the period 2006–2012. Seventy-six percent of women had only one obstetric record (i.e. gave birth
once). The average number was 1.3 and the maximum 6
FGM status was grouped as:
Type I/II = Unknown, Type I, Type I-II, Type II
Type III = Type II/III, Type III
bEast Africa is defined as Tanzania, Burundi, Rwanda, Uganda, Sudan, Ethiopia, Eritrea, Djibouti, Somalia, and Kenya. Western and Southern African countries
include Sierra Leone, Liberia, Guinea, Nigeria and the Democratic Republic of Congo. North Africa and the Middle East categories include Egypt, Iran, Iraq, Saudi
Arabia and Yemen. Women from Asia were from Pakistan, Sri Lanka, Indonesia and Singapore
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Interpretation
In 2004, 1.4 % of babies born in all maternity services in
England and Wales were to women affected by FGM
[19]. Our figure of 2 to 3 % for the study hospital would
be lower nationally, as this hospital is known for its
FGM expertise. Women born in countries where FGM
is prevalent, live near it, and hence are referred to this
hospital. Eighty-nine percent of women who were born
in these countries, lived in major cities in Australia in
2011 [20].
In keeping with our findings of ObstetriX recording of
FGM type, a study in Switzerland reported that FGM
identification were missed in 37 % and the type
Table 5 Perinatal outcomes for women who have FGM recorded and have an obstetric record at study hospital between 2006 and
2012
FGM status FGM status
Type III Type I/II No Type III Type I/II No
n n n Rate per 100 births (95 % CI) Rate per 100 births (95 % CI) Rate per 100 births (95 % CI) P-value
Outcome
Caesarean sectiona
Yes 16 36 1706 26.5 (16.6, 42.4) 32.9 (24.5, 44.0) 20.4 (19.5, 21.4) 0.0041
No 49 95 7145
Instrumental birthsa
Yes 1 8 574 1.6 (0.2, 11.2) 6.2 (2.9, 13.1) 6.5 (6.0, 7.1) 0.36
No 64 123 8277
Episiotomy (excluding anterior episiotomy)
Yes 7 17 946 10.5 (5.0, 21.8) 12.7 (7.5, 21.5) 10.9 (10.2, 11.5) 0.84
No 58 114 7906
3rd and 4th degree perineal tearb
Yes 0 0 85 0.0 0.0 1.0 b
No 65 131 8767
Genital tract trauma
Yes 4 2 99 6.0 (2.4, 14.8) 1.4 (0.4, 5.6) 1.1 (0.9, 1.4) 0.0015
No 61 129 8753
Postpartum blood loss > 500 ml
Yes 1 7 615 1.6 (0.2, 11.6) 5.6 (2.7, 11.4) 7.0 (6.5, 7.6) 0.29
No 64 124 8237
Low birth weight (<2500 g)a
Yes 2 4 259 3.5 (0.9, 13.8) 3.1 (1.2, 8.1) 3.0 (2.6, 3.4) 0.97
No 63 127 8590
Admission to special care nursery
Yes 6 16 616 9.0 (3.9, 20.7) 12.0 (7.5, 19.2) 7.0 (6.5, 7.6) 0.07
No 59 115 8236
Stillbirthc
Yes 1 1 39 1.5 (0.2, 10.9) 0.8 (0.1, 5.3) 0.4 (0.3, 0.6) 0.41
No 64 130 8812
aOne woman’s record had missing mode of birth and three records had missing birth weight
bStatistical model could not be fitted due to small numbers
cOne woman’s record had missing stillbirth indicator
Table 6 Proportion (%) of nulliparous women who had a
caesarean section, by FGM type for women who have an
obstetric record for the period 2006 to 2012 at study hospital
FGM Status FGM Status
Type III Type I/II No Type III Type I/II No
n n n % % %
Outcome
Caesarean sectiona
Yes 6 15 697 46.2 38.5 20.3
No 7 24 2744
aOne obstetric record had missing mode of birth
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misclassified in 23 % [21]. There is no data on FGM
prevalence in Australia. Similarly, in the European
Union, data relevant to FGM is neither systematically
collected nor centrally stored [19]. Accurate data is im-
portant in developing evidence-based policies to appro-
priately implement prevention programmes, health
services, monitor their effectiveness, and assess how in-
tegration processes affect the practice [19]. It is import-
ant to again stress the fact that a radical change occurs
in families to oppose and/or abandon FGM after migra-
tion [13], and we can expect a very low number of chil-
dren being cut in their new countries. Hence, while it is
paramount to prevent and protect girls from FGM in a
similar way as we do with child abuse, it is also import-
ant to focus on the issues surrounding social integration
and education to aid the cultural change.
The WHO study found that obstetric complications
increased with severity of FGM type [9]. The study cen-
tres varied from isolated rural hospitals to tertiary teach-
ing hospitals in capital cities. In our study, most of the
women had the more severe types II and III and obstet-
ric outcomes were similar to women without FGM ex-
cept for caesarean section and first and second degree
perineal tears. The findings of our study are in keeping
with those of other high-income countries, which show
that high quality obstetric care with expertise in FGM
can minimise obstetric complications [22–25].
A study in Switzerland found statistically higher inci-
dences of caesarean section and third degree perineal
tears in women with FGM III [24]. The majority of their
122 patients had been deinfibulated. The main reason
for the emergency caesarean sections, however, was the
inability to perform a vaginal examination in labour in
women with FGM III who had not been deinfibulated.
We do not know whether the caesarean section rate
would still have been higher if all women had been dein-
fibulated and allowed to continue to labour. There was
no difference in the length of labour between women
with and without FGM. The latter finding was supported
by a study of women who underwent deinfibulation at
vaginal delivery at a tertiary referral hospital in Saudi
Arabia [26]. There were no differences in obstetric and
perinatal outcomes. No caesarean section was performed
for the indication of FGM. The strength of that study
was that the women were matched to those of the same
nationalities. A UK study showed that reversal of FGM
III significantly reduced the increased risk of caesarean
delivery seen with multiparae who have FGM III [27]. A
Swedish study examined 68 nulliparous women who had
mainly FGM III and were deinfibulated in labour [23]. It
found that women with FGM even had a lower risk of
prolonged labour.
On the other hand, in keeping with findings from the
WHO study [9], the above obstetric outcomes have been
found to be different in low-income countries. A study
of 85 women in Burkina Faso again showed that women
with FGM had a higher risk of caesarean section [28].
The indications were cephalopelvic disproportion and
prolonged labour with fetal distress. The study also
found higher risks of episiotomy, neonatal resuscitation
and stillbirth in women with FGM. These findings were
supported by a prospective study in The Gambia [29].
FGM did not affect the main reason of cephalopelvic
disproportion for caesarean section. The authors posited
that caesarean sections were performed preventively for
severe abnormal scarring and/or synaechiae in women
with FGM II [29].
Studies of Somali-born women in high-income coun-
tries (HIC) of migration reveal significantly adverse peri-
natal outcomes as compared to receiving country-born
women [17, 19, 20, 30]. A meta-analysis of these women
in six countries showed that they were more likely to
labour without any analgesia or epidural [17]. Language
and communication barriers were considered to be con-
tributing factors to the differences in the use of pain re-
lief [17]. These may then also affect the increased
number of caesarean section, which occurred despite the
fact that Somali women prefer vaginal birth and have an
aversion to caesarean section [19, 26, 27]. This fear of
caesarean section understandably arises from having
lived in a country with a high maternal mortality rate.
One of the reasons could be late presentation of women
to hospital when a caesarean section is performed but
the complications are too advanced to safe a woman’s
life. Moreover, women may die from uterine rupture
with subsequent pregnancies following a caesarean sec-
tion, as there may be no access to appropriate obstetric
care. These women’s beliefs regarding safe birth need to
be explored and addressed early in their antenatal care.
A qualitative study of pregnancy and childbirth experi-
ences in Somalian women in Sweden proposes a rela-
tionship between adverse perinatal outcome and cultural
factors [31]. A comparison of these studies from HIC
with otherwise high-quality obstetric care with those of
the HIC above suggests that culturally sensitive care and
FGM expertise by the obstetrician and midwife are likely
to play important roles in providing optimal perinatal
care. The higher caesarean section rate in our study is
unclear. A prospective multicentre study in countries of
migration comparing women with and without FGM of
same ethnicities would be required to provide that infor-
mation. Moreover, the study hospitals would need to
provide similar standards of obstetric care and FGM
expertise.
Our study hospital underlines the importance of inte-
grating specialised FGM units into hospitals that care
for women with FGM. They would provide holistic
healthcare, including gynaecological and obstetric care
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with deinfibulation procedures, integrated with culturally
appropriate counseling, psychological, sexual and social
support services. There need to be referral pathways for
healthcare professionals, hospitals, schools, social work,
child protection, immigration and judicial sectors, the
police and nongovernment organisations working with
affected communities. Training in FGM and its legal and
health implications for women and their families can be
integrated in these sectors.
In Australia and other countries where women with
FGM live, there is a concern about the cultural compe-
tence, experience and training of healthcare professionals
in the management of FGM [32–36]. The comparison of
the ObstetriX and specialised Midwives Databases in our
study show a significant improvement in the accuracy of
FGM recording from 14 to 90 % over six years, indicating
increasing knowledge of midwives through teaching of the
Clinical Midwifery Consultant. Our study highlights the
importance of education and training of healthcare pro-
viders in FGM diagnosis and care. These may be formally
incorporated into undergraduate and postgraduate nurs-
ing and medical programmes.
Conclusion
Women with FGM had similar obstetric outcomes to
women without FGM in an Australian metropolitan hos-
pital with FGM expertise. There was an increased rate of
caesarean section and genital tract trauma of first and
second degree perineal tears. The indications for the
caesarean sections were not FGM.
There was significant improvement in midwifery ex-
pertise in FGM diagnosis over seven years with forma-
lised training and education at the study hospital. Our
findings underline the benefits of providing care for
women with FGM in a specialised centre.
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